Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Can pragmatic clinical trials and optimisation of treatments support development, access and value?

The Cancer Medicine Forum of the EMA

Date

14 Sep 2024

Session

Can pragmatic clinical trials and optimisation of treatments support development, access and value?

Topics

Cancer Research

Tumour Site

Presenters

Francesco Pignatti

Authors

F. Pignatti

Author affiliations

  • Office Of Oncology And Haematology, European Medicines Agency - Amsterdam, 1083 HN - Amsterdam/NL

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Pragmatic trials: General introduction

Presenter: Denis Lacombe

Session: Can pragmatic clinical trials and optimisation of treatments support development, access and value?

Resources:

Slides

Webcast

RCT and RWD for HTA decision making

Presenter: Beate Wieseler

Session: Can pragmatic clinical trials and optimisation of treatments support development, access and value?

Resources:

Slides

Webcast

Q&A and discussion

Session: Can pragmatic clinical trials and optimisation of treatments support development, access and value?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.